Cargando…
Nebivolol Ameliorates Nitric Oxide–Deficient Hypertension
Nebivolol is a new selective beta 1-adrenoceptor antagonist with nitric oxide (NO)–releasing properties. In the present study we have analyzed whether nebivolol affects the development of the arterial hypertension that follows the chronic inhibition of nitric oxide synthesis. Nebivolol (1 mg/kg/day,...
Autores principales: | Fortepiani, L.A., Ortiz, M.C., Atucha, N.M., Garcia-Estan, Joaquin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009747/ https://www.ncbi.nlm.nih.gov/pubmed/12806161 http://dx.doi.org/10.1100/tsw.2002.814 |
Ejemplares similares
-
Altered calcium signaling in platelets from nitric oxide-deficient hypertensive rats
por: Iyú, David, et al.
Publicado: (2004) -
Omapatrilat normalizes renal function curve in spontaneously hypertensive rats
por: Morazo, Paloma, et al.
Publicado: (2001) -
Role of Nitric Oxide in the Altered Calcium Homeostasis of Platelets from Rats with Biliary Cirrhosis
por: Akbari Aghdam, Masoud, et al.
Publicado: (2023) -
Nitric oxide mediated the effects of nebivolol in cardiorenal syndrome
por: Mercanoglu, Guldem, et al.
Publicado: (2019) -
Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation
por: Weiss, Robert
Publicado: (2006)